Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19.

Intern Emerg Med · 2020 · PMC7233190 · PMID 32424634

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

In another study on hospitalized COVID-19 patients, the percentage of hypertensive patients taking ACE-I/ARB did not differ between those with severe and non-severe infection or between non-survivors and survivors, with a favorable trend for ACE-I/ARB, although adjusted analysis was not performed [ 7 ].

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.